# Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma

> **NCT00003052** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 340 (estimated)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** hyperthermia treatment
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003052
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-07
- **Primary completion:** —
- **Final completion:** 2010-06
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2013-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003052, "Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*